Application 021124

Type
NDA
Sponsor
GLAXOSMITHKLINE CONS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LAMISIL ATTERBINAFINE HYDROCHLORIDESOLUTION;TOPICAL1%YesYes
002LAMISIL ATTERBINAFINE HYDROCHLORIDESPRAY;TOPICAL1%YesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021124-001LAMISIL ATTERBINAFINE HYDROCHLORIDE1%SOLUTION / TOPICALRLD, RS2000-03-17
N021124-002LAMISIL ATTERBINAFINE HYDROCHLORIDE1%SPRAY / TOPICALRLD, RS2000-03-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-172680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-175bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17d06236e962d9…
2024-10-29 15:01 UTC2024-10N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-171e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-178072bd15b7f6…
2024-05-31 18:47 UTC2024-05N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-175c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-175d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-174b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1774a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1774a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17782e0a99824c…
2021-12-28 21:50 UTC2021-12N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17782e0a99824c…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lamisil ATTERBINAFINE HYDROCHLORIDEKaro Healthcare Inc.21f1bf77-4338-4b75-b513-80a0d98a722a2025-12-12WarningsExact identifier
application applno (NDA): 021124
application number: NDA021124
Lamisil ATTERBINAFINE HYDROCHLORIDEKaro Healthcare Inc.d3e75665-e2d4-47d9-baaa-93817b5fbf002025-12-12WarningsExact identifier
application applno (NDA): 021124
application number: NDA021124

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 9 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0067-6292LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0067-6292LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0067-6293LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer NDACurrent
0067-6296LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0067-6296LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0067-6296LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0067-6297LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0067-6297LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0067-6297LAMISILTERBINAFINE HYDROCHLORIDEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
56098SUPPL2018-10-26
56068SUPPL2018-10-23
36163SUPPL2013-11-19
4389SUPPL2013-11-15
4388SUPPL2012-03-26
4387SUPPL2010-02-22
4386SUPPL2009-06-17
26833SUPPL2008-07-31
41965ORIG2002-05-15
14442ORIG2000-03-17
4385ORIG2000-03-17